Author

J. T. Fuller

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 2 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Research Focus:host-pathogen & immune response· 2 Assay:proteomics· 2 Organism:rat· 2 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Assay:flow cytometry· 1

Frequent Co-Authors

D. H. Fuller· 3 shared M. A. O'Connor· 2 shared A. C. Walls· 1 shared A. Chahroudi· 1 shared A. Lippy· 1 shared A. Palser· 1 shared A. Schaefer· 1 shared B. Brown· 1 shared

Activity by Year

2020-2020 · peak 3/yr

Co-Author Collaboration Network

10 top collaborators · 27 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersImmunology

D. H. Fuller

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Rapid progression is associated with lymphoid follicle dysfunction in SIV-infected infant rhesus macaques

M. P. Wood, C. I. Jones, A. Lippy, B. G. Oliver, B. Walund, K. A. Fancher, B. S. Fisher, P. J. Wright, J. T. Fuller, P. Murapa, J. Habib, M. Mavigner, A. Chahroudi, D. N. Sather, D. H. Fuller, D. Sodora

This study identifies lymphoid follicle dysfunction as a key factor in rapid disease progression in SIV-infected infant rhesus macaques.

bioRxiv · Dec 31, 2020Immunology

Protection from viral rebound after therapeutic vaccination with an adjuvanted DNA vaccine is associated with SIV-specific polyfunctional CD8 T cells in the blood and mesenteric lymph nodes

H. C. Tunggal, P. V. Munson, M. A. O'Connor, N. Hajari, S. E. Dross, D. Bratt, J. T. Fuller, K. Bagley, D. H. Fuller

This study shows that a therapeutic DNA vaccine with adjuvants protects some SIV-infected macaques from viral rebound by enhancing polyfunctional CD8 T cells in blood and gut lymph nodes.

bioRxiv · Sep 16, 2020 · PreprintMicrobiology

Elicitation of potent neutralizing antibody responses by designed protein nanoparticle vaccines for SARS-CoV-2

A. C. Walls, B. Fiala, A. Schaefer, S. Wrenn, M. N. Pham, M. Murphy, L. V. Tse, L. Shehata, M. A. O'Connor, C. Chen, M. J. Navarro, M. C. Miranda, D. Pettie, R. Ravichandran, J. C. Kraft, , N. P. King

This study designs SARS-CoV-2 nanoparticle vaccines that induce strong neutralizing antibodies in mice, with higher titers and lower doses than existing trimer vaccines.

bioRxiv · Aug 11, 2020Immunology